ijms-logo

Journal Browser

Journal Browser

Novel Mechanisms for the Prevention and Treatment of Stroke

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 10 February 2026 | Viewed by 699

Special Issue Editor


E-Mail Website
Guest Editor
NeuroCardioMetabol Group, Department of Clinical Science and Education, Södersjukhuset, Internal Medicine, Karolinska Institutet, 118 83 Stockholm, Sweden
Interests: stroke; diabetes; obesity; neuroplasticity; neurogenesis; neuroprotection
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent decades, the incidence of ischemic stroke has decreased thanks to improved control of important risk factors. Furthermore, the handling of acute stroke involving the chemical and/or surgical removal of thrombotic clots has demonstrated considerable improvement. However, two in three patients with ischemic stroke die or are functionally dependent at 5 years post-stroke, and this remains one of the leading causes of death and serious disability across the world. Moreover, such numbers are expected to rise over the next few decades, primarily due to population growth/aging and comorbidities. This underlines the importance of research in this field aiming to identify new molecular and cellular targets leading to stroke, as well as those triggered after stroke and characterizing stroke pathophysiology. Once these mechanisms have been identified, new proof-of-concept studies are needed to test their therapeutic potential.

In this Special Issue of the International Journal of Molecular Sciences, authors are invited to submit a wide range of both basic research and clinical papers showing novel data about the identification of molecular and cellular mechanisms whose targeting may be important to both preventing and treating stroke; this with the aim of contributing to the international stroke research community. These papers can also focus on the effects of stroke comorbidities on newly identified cellular and molecular mechanisms, with particular focus on diabetes, dyslipidemia, depression, hypertension, obesity and heart disease, and vascular complications.

Dr. Cesare Patrone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stroke
  • pathophysiology
  • mechanisms
  • comorbidities
  • treatments

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 249 KB  
Article
Pilot Exploratory Analysis of Serum Gonadal Hormones, Inflammatory Proteins, and Intracerebral Hemorrhage Outcomes
by Yisi Ng, Wenjing Qi, Anna Covington, Bobby Boone IV, Cynthia Kuhn, Andrew B. Nixon, Nicolas Kon Kam King, Peter F. Kranz, Thomas Christianson, Roshni Thakkar, Daniel T. Laskowitz, Cina Sasannejad, Miran Bhima, Vijay Krishnamoorthy, Shreyansh Shah, Amy K. Wagner and Michael L. James
Int. J. Mol. Sci. 2025, 26(17), 8334; https://doi.org/10.3390/ijms26178334 - 28 Aug 2025
Viewed by 593
Abstract
Intracerebral hemorrhage (ICH) remains the least treatable form of stroke, with inflammation implicated as a major pathophysiological feature. Hence, this study sought to associate serum proteins and hormones associated with inflammation and ICH outcomes. Patients presenting to Duke University Hospital with computed tomography-verified [...] Read more.
Intracerebral hemorrhage (ICH) remains the least treatable form of stroke, with inflammation implicated as a major pathophysiological feature. Hence, this study sought to associate serum proteins and hormones associated with inflammation and ICH outcomes. Patients presenting to Duke University Hospital with computed tomography-verified spontaneous, supratentorial, non-traumatic ICH within 24 h of symptom onset were prospectively recruited. In this pilot study, equal numbers of men and women and Black and White individuals were included and matched by a 6-month modified Rankin Score (mRS). The primary analyses were the correlation of L-ratios (LR; Log2(Day 2/Day 1 concentrations)) of serum gonadal hormones and neuroinflammatory proteins with mRS > 3 at 6 months. A total of 40 participants were included in this pilot study. LRs were significantly higher for C-reactive protein (CRP; p = 0.013) and lower for interleukin-6 (IL-6; p = 0.026) and surfactant protein-D (p = 0.036) in participants with unfavorable outcomes at 6 months after ICH. Further, higher CRP (p = 0.02) and lower IL-6 (p = 0.035) and surfactant protein-D (p = 0.041) LRs were associated with mRS > 3 at 6 months after ICH in multiple logistic regression analyses, adjusted for race and sex. The relationship amongst gonadal hormones, neuroinflammatory proteins, and ICH outcome is complex. In this pilot study, unfavorable outcomes after ICH may have been associated with selected inflammatory biomarkers. A larger scale study is warranted to define interactions between hormones, proteins, and their effects on ICH outcomes. Full article
(This article belongs to the Special Issue Novel Mechanisms for the Prevention and Treatment of Stroke)
Back to TopTop